Clinical Trials on Lymphoma, Non-Hodgkin's, Adult
Total 5708 results
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited States, United Kingdom
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited Kingdom
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid TumorCanada, United States
-
AbbVieGenentech, Inc.WithdrawnRelapsed/Refractory Non-Hodgkin's Lymphoma
-
University of NebraskaMillennium Pharmaceuticals, Inc.CompletedMantle Cell Lymphoma | Non-hodgkin's LymphomaUnited States
-
Hoffmann-La RocheAbbVieCompletedFollicular LymphomaUnited States, Italy, Canada, Australia, Belgium, United Kingdom, Germany, France
-
Ascenta TherapeuticsCompletedFollicular LymphomaUnited States
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Non-Hodgkin's LymphomaHong Kong, Germany, Philippines, Taiwan, Turkey, Canada, Australia, Austria, New Zealand, Thailand, Hungary, Italy, Korea, Republic of, Romania, Netherlands, Brazil, Indonesia, Croatia, Egypt, Portugal, Sweden, Colombia, Argentina, De... and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation RecipientUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
Mehrdad Abedi, MDAmgenCompletedStage IV Adult Lymphoblastic Lymphoma | Contiguous Stage II Adult Lymphoblastic Lymphoma | Noncontiguous Stage II Adult Lymphoblastic Lymphoma | Stage I Adult Lymphoblastic Lymphoma | Stage III Adult Lymphoblastic Lymphoma | Untreated Adult Acute Lymphoblastic LeukemiaUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingB-cell Non Hodgkin LymphomaChina
-
AbClonRecruitingB-cell Non Hodgkin LymphomaKorea, Republic of
-
University of ChicagoActive, not recruitingCLL | B-cell Non Hodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; University of Washington; H. Lee...Active, not recruiting
-
UWELL BiopharmaTri-Service General HospitalUnknownB-cell Non-Hodgkin LymphomaTaiwan
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaSpain
-
The Lymphoma Academic Research OrganisationRoche Pharma AGTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin LymphomaFrance
-
Beth ChristianCompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma | Adult Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
Case Comprehensive Cancer CenterActive, not recruitingNon-hodgkin LymphomaUnited States
-
Benjamin TomlinsonActive, not recruitingNon-Hodgkin LymphomaUnited States
-
New York Medical CollegeCompletedNon Hodgkin Lymphoma
-
AstraZenecaTerminatedNon-Hodgkin LymphomaSpain, United States, Korea, Republic of, France, Portugal, Australia, Italy
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Tahir LatifActive, not recruitingNon Hodgkin LymphomaUnited States
-
Spectrum Pharmaceuticals, IncThe Leukemia and Lymphoma SocietyTerminated
-
ImmunityBio, Inc.Withdrawn
-
Timmune Biotech Inc.Unknown
-
Alberta Health Services, CalgaryUnknownNon-Hodgkin LymphomaCanada
-
Gustave Roussy, Cancer Campus, Grand ParisSociété Française des Cancers et Leucémies de l'Enfant et de l'Adolescent...Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Kjeld SchmiegelowOdense University Hospital; Aarhus University Hospital Skejby; Aalborg University...WithdrawnNon-Hodgkin LymphomaDenmark
-
Seagen Inc.Genentech, Inc.Completed
-
National University Hospital, SingaporeCompleted
-
Centre de recherche du Centre hospitalier universitaire...Unknown
-
Hoffmann-La RocheActive, not recruitingNon-Hodgkins LymphomaBelgium, Spain, Denmark, Italy, United Kingdom, Israel, United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Bristol-Myers SquibbSeagen Inc.CompletedNon-Hodgkin's DiseaseUnited States, France, Canada, United Kingdom, Italy, Spain
-
Sohag UniversityNot yet recruiting
-
Centre Hospitalier Universitaire DijonRecruitingNon-hodgkin's LymphomaFrance
-
Xynomic Pharmaceuticals, Inc.Cancer Institute and Hospital, Chinese Academy of Medical SciencesActive, not recruitingNon Hodgkin LymphomaChina
-
MorphoSys AGCompletedNon-Hodgkin LymphomaUnited States, Belgium, Germany, Hungary, Italy, Poland, Spain
-
Gilead SciencesTerminated
-
Assiut UniversityCompleted
-
Novartis PharmaceuticalsCompletedNeoplasms | Non-Hodgkin LymphomaUnited States, Netherlands
-
Institut Paoli-CalmettesCompletedNon-Hodgkin LymphomaFrance
-
University of BelgradeUnknownNon-hodgkin LymphomaSerbia
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.The First Affiliated Hospital of Zhengzhou UniversityUnknown
-
Nordic NanovectorWithdrawnNon-Hodgkin LymphomaGermany